SONENDO INC (SONX)       2.56  -0.04 (-1.54%)

2.56  -0.04 (-1.54%)

US8354311073 - Common Stock


Fundamental Rating

3

Overall SONX gets a fundamental rating of 3 out of 10. We evaluated SONX against 223 industry peers in the Health Care Equipment & Supplies industry. SONX scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. SONX is quite expensive at the moment. It does show a decent growth rate.

Note: SONX has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

SONX has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SONX.

VS Industry

Valuation

Valuation Rating

2

When comparing the price book ratio of SONX to the average industry price book ratio of 2.90, SONX is valued rather cheaply.
When comparing the current price to the book value of SONX, we can conclude it is valued correctly. It is trading at 1.41 times its book value.

SONX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SONX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Price/Book (1.41) VS Industry: 73% outperformed.

1,369.61
0.21

Growth

Growth Rating

6

The Earnings Per Share is expected to grow by 17.97% on average over the next 5 years. This is quite good.
The Revenue has grown by 42.17% in the past year. This is a very strong growth!

The Revenue is expected to grow by 35.28% on average over the next 5 years. This is a very strong growth
SONX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.89%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -3.89% 51.46% 32.43% 22.05% 17.97%
RevenueN/A N/A 42.17% 26.62% 29.57% 36.08% 35.28%

Health

Health Rating

4

A Current Ratio of 8.86 indicates that SONX has no problem at all paying its short term obligations.
The Current Ratio of SONX is much better than the industry average of 3.69. SONX has a better rating than 86% of its industry peers.
A Quick Ratio of 7.80 indicates that SONX has no problem at all paying its short term obligations.
SONX is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.91. SONX has a better rating than 85% of its industry peers.

Compared to an average industry Debt to Equity Ratio of 0.11, SONX is more dependent on financing than its industry peers.
SONX has an Altman-Z score of -2.13. This is a bad value and indicates that SONX is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of SONX to the average industry Altman-Z score of 1.97, SONX is less financially healthy than its industry peers.
SONX has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SONX.
VS Industry

Debt/Equity (0.41) VS Industry: 32% outperformed.

336.87
0.00

Quick Ratio (7.8) VS Industry: 85% outperformed.

0.06
33.20

Current Ratio (8.86) VS Industry: 86% outperformed.

0.12
33.20

Altman-Z (-2.13) VS Industry: 32% outperformed.

-101.74
78.21

Dividend

Dividend Rating

0

No dividends for SONX!.

SONENDO INC2.56

NYSE:SONX (2/3/2023, 7:08:44 PM)-0.04 (-1.54%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Equipment & Supplies
Earnings (Last) 11-09 2022-11-09/amc Earnings (Next) N/A N/A
Inst Owners N/A Inst Owner Change N/A
Ins Owners 5.34% Ins Owner Change -1.46%
Market Cap 127.38M Analysts 83.64
Price Target 3.52 (37.5%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -4.46%
Min EPS beat(2) -8.42% Max EPS beat(2) -0.51%
EPS beat(4) N/A Avg EPS beat(4) -14.01%
Min EPS beat(4) -41.18% Max EPS beat(4) -0.51%
Revenue beat(2) 2 Avg Revenue beat(2) 2.92%
Min Revenue beat(2) 2.15% Max Revenue beat(2) 3.69%
Revenue beat(4) 4 Avg Revenue beat(4) 4.63%
Min Revenue beat(4) 2.15% Max Revenue beat(4) 7.72%
PT rev (1m) -5.99% PT rev (3m) -21.23%
EPS NQ rev (1m) 0% EPS NQ rev (3m) 25.54%
EPS NY rev (1m) 0% EPS NY rev (3m) -0.11%
Revenue NQ rev (1m) 0% Revenue NQ rev (3m) -3.78%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.22%

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.6
EV/EBITDA N/A
EPS(TTM) -2.35 EY N/A
EPS(NY) -0.77 Fwd EY N/A
FCF(TTM) -1.26 FCFY N/A
OCF(TTM) -1.24 OCFY N/A
SpS 0.79 BVpS 1.82
TBVpS 1.6 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 24.42%
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 3 Asset Turnover 0.28

Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.84%
Profit Quality N/A
Current Ratio 8.86
Quick Ratio 7.8
Altman-Z -2.13
F-Score 3 WACC 10.39%
ROIC/WACC N/A Cap/Depr(3y) 82.4%
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -3.89% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 95.45%
EPS Next Y 51.46% EPS Next 2Y 32.43%
EPS Next 3Y 22.05% EPS Next 5Y 17.97%
Revenue growth 1Y 42.17% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q 24.84%
Revenue Next Year 26.62% Revenue Next 2Y 29.57%
Revenue Next 3Y 36.08% Revenue Next 5Y 35.28%
EBIT growth 1Y -3.76% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year -13.9%
EBIT Next 3Y 9.14% EBIT Next 5Y 16.08%
FCF growth 1Y -28.18% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -26.1%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA